**Abstract**

Persistent glucocorticoids (GCs) exposure in chronic stressful stimuli has deleterious effects on the function of neuron and microglia, leading to major depression. In the previous study, we reported that the dysregulation of microglia functional phenotype in chronic stress mice was associated with stress vulnerability and depression relapse. However, the underlying mechanism of glucocorticoid on microglia functional phenotype was not elucidated until now. In this study, we investigated that 72h of dexamethasone (DEX) treatment reduced fractalkine receptor (CX3CR1) and CD200 receptor (CD200R) in primary cultured microglia while 24h of DEX did not. In addition, the effect was abolished by RU386 (Gc antagonist) co-treatment, suggesting that glucocorticoid receptor (GR) mediates the dexamethasone effect on CX3CR1 reduction in microglia. Interestingly, we found that 72 h of DEX treatment increased TNF-α and IL-6 secretion in microglia while 24 h of DEX treatment did not. TNF-α neutralizing antibody co-treatment with DEX also could prevent microglia from reducing CX3CR1 expression. Overall, our results suggest that chronic glucocorticoid exposure reduced M2-like phenotype of microglia (CX3CR1 and CD200R) via TNF-α elevation, which may be involved in stress vulnerability and depression.
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